LAS VEGAS, Nov. 5 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com/) (BULLETIN BOARD: CBAI) , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that it is pleased that Congress has approved, and President Obama has signed, the Stem Cell Therapeutic and Research Reauthorization Act of 2010.
U.S. Senator Jack Reed (D-RI), co-sponsor of the bill, said: "Cord blood is the blood that remains in the placenta and in the attached umbilical cord after childbirth. It is collected because it contains adult stem cells, which can be used to treat a range of diseases." He stressed that the bill will "help thousands of patients suffering from diseases requiring bone marrow and cord blood transplants."
Congressman Chris Smith (R-N.J.), who wrote the original bill in 2005, said, "It remains one of the best kept secrets in America that umbilical cord blood stem cells are curing people of a myriad of terrible conditions and diseases. Umbilical cords are a rich, non-controversial source of stem cells, yet hospitals throw millions of them away each year. This law created a new nationwide umbilical cord blood stem cell program designed to collect, derive, type and freeze cord blood units for transplantation into patients to cure serious diseases such as childhood leukemia."
Matthew Schissler, co-founder, CEO and President of Cord Blood America, said Rep. Smith, in moving to reauthorize the stem cell collection, stressed that research is ongoing to use these cells to do "miraculous things" in the treatment of cerebral palsy, lupus, and genetic diseases including Krabbe disease, Hurler disease and Tay Sachs disease. "We believe there is a place for both public and private storage of umbilical cord blood stem cells and we salute Congress and the President for recognizing this important fact," Mr. Schissler said.
About Cord Blood America
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.
CONTACT: Paul Knopick E & E Communications 949/707-5365 pknopick@eandecommunications.com
Cord Blood America, Inc.
CONTACT: Paul Knopick of E & E Communications, +1-949-707-5365,
pknopick@eandecommunications.com, for Cord Blood America, Inc.
Web Site: http://www.cordblood-america.com/
